Patents by Inventor Karen Margaret Reddin

Karen Margaret Reddin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multicomponent meningococcal vaccine
    Patent number: 10967045
    Abstract: A composition is provided comprising N. meningitidis outer membrane vesicles, wherein said outer membrane vesicles are enriched with at least one antigenic component. The composition is suitable for use in vaccines and for treatment of infection, particularly meningococcal infection, demonstrating a broad spectrum of protection. A number of preferred antigenic components are described and include antigenic proteins and proteoglycans derived from N. meningitidis.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: April 6, 2021
    Assignee: Secretary of State for Health and Social Care
    Inventors: Andrew Robinson, Margaret Robinson, Andrew Richard Gorringe, Michael John Hudson, Karen Margaret Reddin
  • MULTICOMPONENT MENINGOCOCCAL VACCINE
    Publication number: 20110033491
    Abstract: A composition is provided comprising N. meningitidis outer membrane vesicles, wherein said outer membrane vesicles are enriched with at least one antigenic component. The composition is suitable for use in vaccines and for treatment of infection, particularly meningococcal infection, demonstrating a broad spectrum of protection. A number of preferred antigenic components are described and include antigenic proteins and proteoglycans derived from N. meningitidis.
    Type: Application
    Filed: April 12, 2010
    Publication date: February 10, 2011
    Inventors: Andrew Robinson, Margaret Robinson, Andrew Richard Gorringe, Michael John Hudson, Karen Margaret Reddin
  • Multicomponent meningococcal vaccine
    Publication number: 20090148469
    Abstract: A composition is provided comprising N. meningitidis outer membrane vesicles, wherein said outer membrane vesicles are enriched with at least one antigenic component. The composition is suitable for use in vaccines and for treatment of infection, particularly meningococcal infection, demonstrating a broad spectrum of protection. A number of preferred antigenic components are described and include antigenic proteins and proteoglycans derived from N. meningitidis.
    Type: Application
    Filed: October 20, 2008
    Publication date: June 11, 2009
    Inventors: Andrew Robinson, Andrew Richard Gorringe, Michael John Hudson, Karen Margaret Reddin
  • Outer membrane vesicles from gram negative bacteria and use as a vaccine
    Patent number: 7384645
    Abstract: A composition is prepared from a mixture of different vesicles, such as outer membrane vesicles (OMVs) and vaccines are based thereon. Another composition comprises in a single vesicle a combination of antigens and/or other vesicle components deriving from separate vesicles; again vaccines are prepared therefrom.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: June 10, 2008
    Assignee: Health Protection Agency
    Inventors: Keith Alan Foster, Andrew Richard Gorringe, Michael John Hudson, Karen Margaret Reddin, Andrew Robinson
  • Neisserial vaccine compositions and methods
    Patent number: 7157245
    Abstract: Methods and compositions for the treatment of microbial infection, and in particular meningococcal disease, comprise a commensal Neisseria or an extract of a commensal Neisseria. Further methods and compositions comprise commensal Neisseria which express genes from virulent strains of Neisseria and/or heterologous gene products from non-neisserial sources. Such compositions are used in vaccine preparations for the treatment of microbial infection.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: January 2, 2007
    Assignee: Health Protection Agency
    Inventors: Andrew Robinson, Andrew Richard Gorringe, Michael John Hudson, Philippa Bracegirdle, John Simon Kroll, Paul Richard Langford, Steven Anthony Rochford Webb, Keith Cartwright, Cliona Anne O'Dwyer, Karen Margaret Reddin
  • Multicomponent meningococcal vaccine
    Patent number: 6821521
    Abstract: A composition comprising Transferrin binding proteins A and B is described (TbpA and TbpB). The composition is suitable for use in vaccines and for treatment of Gram negative bacterial infection, particularly meningococcal infection, demonstrating a broad spectrum of protection to a number of different bacterial pathogens. Also described are compositions comprising Tbps and other components, such as neisserial outer membrane vesicles and Cu,Zn-Superoxide dismutase. Methods for preparation of these compositions and their uses in vaccination against disease are further provided.
    Type: Grant
    Filed: August 29, 2001
    Date of Patent: November 23, 2004
    Assignee: Health Protection Agency
    Inventors: Andrew Robinson, Andrew Richard Gorringe, Michael John Hudson, Karen Margaret Reddin
  • Multicomponent meningococcal vaccine
    Publication number: 20030215469
    Abstract: A composition is provided comprising N. meningitidis outer membrane vesicles, wherein said outer membrane vesicles are enriched with at least one antigenic component. The composition is suitable for use in vaccines and for treatment of infection, particularly meningococcal infection, demonstrating a broad spectrum of protection. A number of preferred antigenic components are described and include antigenic proteins and proteoglycans derived from N. meningitidis.
    Type: Application
    Filed: December 17, 2002
    Publication date: November 20, 2003
    Applicant: Microbiological Research Authority
    Inventors: Andrew Robinson, Andrew Richard Gorringe, Michael John Hudson, Karen Margaret Reddin
  • Neisserial vaccine compositions and methods
    Publication number: 20030026809
    Abstract: Methods and compositions for the treatment of microbial infection, and in particular meningococcal disease, comprise a commensal Neisseria or an extract of a commensal Neisseria. Further methods and compositions comprise commensal Neisseria which express genes from virulent strains of Neisseria and/or heterologous gene products from non-neisserial sources. Such compositions are used in vaccine preparations for the treatment of microbial infection.
    Type: Application
    Filed: August 31, 2001
    Publication date: February 6, 2003
    Inventors: Andrew Robinson, Andrew Richard Gorringe, Michael John Hudson, Philippa Bracegirdle, John Simon Kroll, Paul Richard Langford, Steven Anthony Rochford Webb, Keith Cartwright, Cliona Anne O'Dwyer, Karen Margaret Reddin